• Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform for Comprehensive Genomic Profiling at AMP 2025

  Nov 11, 2025Feb 10, 2026

• Complete Genomics Highlights Clinical Research Sequencing Solutions and Partnerships at AMP 2025

  Nov 11, 2025Feb 10, 2026

• Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

  Oct 14, 2025Feb 10, 2026

• Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

  Oct 13, 2025Feb 10, 2026

• Complete Genomics, Velsera partner to integrate sequencing and analysis platforms

  Apr 28, 2025Feb 10, 2026

• Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program

  Apr 15, 2025Feb 10, 2026

• Complete Genomics Announces Partnership with BioTuring and the Go Optical STOmics Microscope

  Mar 25, 2025Feb 10, 2026

• Complete Genomics Announces Commercial Partnership with Human Cell Atlas to Offer its Members Stereo-seq Spatial Transcriptomics at NextGen Omics & Spatial Biology Conference

  Mar 25, 2025Feb 10, 2026
• 

  Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting

  Feb 23, 2025Feb 10, 2026
• 

  2024 Year in Review: Complete Genomics’ Innovations and Impact

  Jan 9, 2025Feb 10, 2026